HIV Drugs


FDA Rejects 2 HIV Drugs From Gilead Sciences

Gilead Sciences said Monday that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the Foster Citry company’s manufacturing facilities.



Get every new post delivered to your Inbox.

Join 58,846 other followers